Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation to presentation and Q&A session in connection with publication of Nilar International AB Q1 report 2023

Nilar International AB invites to a digital conference and Q&A session for the presentation of highlights from the first quarter of 2023 on Tuesday, May 9, 2023 at 11:00 CEST.Nilar International AB's report for the first quarter of 2023 will be published on Tuesday, May 9. During the same morning, a digital conference will be held at 11:00 CEST for investors and the media. During the conference, Erik Oldmark, CEO of Nilar International, will give a short speech with highlights from the past quarter and answer questions from investors and the media. For registration and questions before

Bulletin from Bactiguard Holding AB’s (publ) Annual General Meeting

At Bactiguard Holding AB’s (publ) Annual General Meeting (AGM) on 5 May 2023, the following resolutions were made:The AGM adopted the income statements and balance sheets for 2022 and decided that no dividend for the financial year 2022 will be paid. Retained earnings and the company's result for the year will be carried forward. The Board of Directors and CEO were discharged from liability for their administration of the company for the financial year 2022. The AGM resolved that the remuneration until the next AGM shall be paid in an amount of SEK 750 000 respectively to the Chairman

Peptonic signs distribution agreement with Cetro Medical AB in Sweden

Peptonic Medical AB (publ) today announced that the company has signed an exclusive agreement with Cetro Medical for distribution of VagiVital VS Pro and VagiVital AL to gynecology and obstetrics clinics in Sweden.The agreements means that Cetro Medical gets an exclusive right to sell VagiVital in the professional channel, i.e. to hospital and clinics. The agreement spans over three years with possible extension. "In Cetro Medical we get a resourceful partner with a long and successful experience in distribution of products for gynecology and obstetrics. This is a partnership and a

Tips on How to Add Natural Light to Your Home

Bringing natural light into your home is always better than adding artificial lights. Natural light bathes the rooms in your home with a rich, full-spectrum hue that electric lightbulbs simply cannot duplicate. This natural lighting helps to increase the feel-good serotonin levels in your body. Plus, natural light is free of charge, unlike electric lights that contribute to your monthly power bills.   [A picture containing text, window, interior design, furniture Description automatically generated]   Many homes aren’t built with natural light in mind. Unfortunately, you can’t

Trading of own shares as part of employee’s savings scheme

SpareBank 1 SR-Bank ASA has on 5 May 2023 purchased 25 333 own shares at an average price of 119.0408. Total holdings of own shares after the purchase is 72 768 shares. The shares were acquired as part of SpareBank 1 SR-Bank’s savings scheme for employees. For more information about the saving scheme reference is made to the stock exchange notice dated 19 December 2022, and the stock exchange notice dated 14 April 2023. As part of SpareBank 1 SR-Bank ASA savings scheme the company will acquire additional shares, up to a number of 76 000, within 31 May 2023.

Trade subject to notification for primary insiders

Alexander Opstad, Group Executive Vice President in DNB Bank ASA, has on 5 May 2022 transferred 12 000 shares in DNB Bank ASA at a share price of NOK 184,70 to Chaos Capital AS, which is a wholly owned investment company of Opstad. The shareholding of Alexander Opstad, including close associates, is unchanged at 56 662 shares after the transfer. See attachment for further details. This information is subject to the disclosure requirements according to MAR article 19 and section 5-12 of the Norwegian Securities Trading Act.

AUDIBLE AND MOONBUG ENTERTAINMENT LAUNCH ORIGINAL FAMILY LISTENING PODCASTS

The collaboration will bring unique audio experiences based on Moonbug's hit shows Little Baby Bum and Lellobee City Farm exclusively to AudibleMay 4, 2023 – Today, Audible , a world-wide leading provider of spoken word entertainment, and Moonbug Entertainment , the award-winning global entertainment company behind some of the most popular kids’ content in the world, announced two original family listening podcasts, Little Baby Bum: Time to Dream and Lellobee City Farm: Grandma Mei's Fantastic Folktales. The two series, based on Moonbug’s

Information regarding CEO of Cline Scientific AB

Cline Scientific AB's CEO and board member Patrik Sundh has been informed that he has been served with suspicion of market manipulation and is subject to a preliminary investigation. The suspicions relate to the purchase of B shares in Cline to a value of approximately SEK 62,000, which was carried out during November 2022.The board will not take any measures at the moment, but is awaiting the results of the preliminary investigation and continues to have full confidence in the CEO. Until the preliminary investigation is completed or closed, no further information will be provided in

Investment AB Latour (publ) issues bond loans

Today Investment AB Latour issued two bond loans of in total SEK 1,500 m, within the aggregate nominal amount of the existing MTN program. The first bond loan amounts to SEK 400 m with a tenor of 2.9 years and carries a floating interest rate of three months STIBOR + a margin of 0.87 per cent annually. The second bond loan amounts to SEK 1,100 m with a tenor of 2.9 years and carries a fixed interest rate of 4.078 per cent annually. Handelsbanken and SEB have arranged the issuance. Göteborg, May 5, 2023 INVESTMENT AB LATOUR (PUBL)Johan Hjertonsson, CEO For further information,

Scandinavian ChemoTech Animal Care unit installs its first commercial installation at Evidensia

Vetiqure AB installs the vetIQure™ system at Evidensia Specialist Horse Hospital in Strömsholm with a rental agreement that can generate income of at least EUR 15,000/year.Chief veterinarian Elin Skärlina has, during an evaluation program, treated a number of patients with Tumour-Specific Electroporation, TSE, and has now also received extended training in connection with the treatment of a horse with over 30 melanomas on its body. Melanomas are skin tumours that in horses are also called mold nodules because they are significantly more common on greys (a name for a horse that has

Wulff Group Plc: Manager Transaction – Kari Juutilainen

MANAGERS’ TRANSACTIONS | MAY 5, 2023 AT 4.00 P.M. Wulff Group Plc has received a notification from Kari Juutilainen, Wulff Group Plc’s Board of Directors Chairman, of a transaction made with its financial instrument, according to the EU Market Abuse Regulation. Detailed information about the transaction is given in the table below. Name: Kari JuutilainenPosition: Board of Directors MemberIssuer: Wulff Group PlcLEI: 74370016PW2V4W02LX91Notification type: Initial notificationReference

Gambling White Paper: Industry Affiliates React

Last Thursday saw the much-anticipated Gambling White Paper announced in Parliament, which consolidated the findings of a lengthy gambling law review.What was covered? The Department of Culture, Media, and Sport (DCMS) intends to implement a maximum bet per spin for slot machines and will consult on a range between £2 and £15 per spin. Players who lose £1,000 within 24 hours or £2,000 within 90 days will be subject to extensive affordability tests. Meanwhile, operators will be required to conduct "passive" inspections on players whose monthly net losses exceed £125, or £500 annually.

Calliditas Announces Late-Breaking Presentations at the 60th European Renal Association (ERA) Congress 2023

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) announced upcoming data presentations from the NeflgArd Phase 3 Study at the European Renal Association (ERA) Congress 2023.These data presentations will feature data and analyses from the NefIgArd Phase 3 clinical trial evaluating Nefecon (TARPEYO[®] (budesonide) delayed release capsules/Kinpeygo[®]) in patients with IgA nephropathy (IgAN). ERA will be held virtually and in Milan, Italy, June 15-18, 2023.  “We are delighted that these data presentations have been selected for the upcoming ERA Congress 2023

Notice to the Annual General Meeting of Bioretec Ltd

Bioretec Ltd                         Company announcement                5 May 2023 at 3.15 p.m. EESTThe shareholders of Bioretec Ltd are hereby invited to the Annual General Meeting of shareholders to be held on 26th of May 2023 at 11:00 a.m. (Finnish time) at Bioretec premises in the auditorium of Tampark, at the address Yrittäjänkulma 5, FI-33710 Tampere, Finland.   A shareholder may participate in the Annual General Meeting and exercise their rights at the meeting by way of proxy representation. A proxy representative shall present a dated power of attorney or in another reliable

Cinis Fertilizer receives the environmental permit for its first production plant

The Swedish Land and Environment Court in Umeå today announced that an environmental permit has been granted to Cinis Fertilizer AB regarding the production of mineral fertilizer in Köpmanholmen, Örnsköldsvik municipality.“It is very gratifying that we have now received a permit for our operations, and we look forward to claiming the permit. We are thus following our schedule, which means that we will start production of fossil free fertilizer already beginning of next year,” says Jakob Liedberg, CEO Cinis Fertilizer. During the first quarter of 2023, Cinis Fertilizer has completed the

Petter Bäckgren presents Bioservo at Redeye Medtech Event

On May 10 at 13:45, Bioservo's CEO, Petter Bäckgren, will present the latest news from the company at Redeye Medtech Event. The presentation will be broadcast live and can be followed on https://www.redeye.se/events/870864/redeye-medtech-event where the recording and presentations will also be available afterward. Bioservo is a world-leading company in portable, muscle-strengthening systems for the hands that is entering an exciting expansion phase. During the first quarter, the company began delivering a completely new generation of Carbonhand to patients with impaired hand

Report from Extraordinary General Meeting in Intervacc

Intervacc AB (publ) has held its Extraordinary General Meeting (”EGM”) on Friday 5 May 2023, at which a resolution on authorisation for the board of directors to resolve on rights issue of shares was made The EGM authorised the board of directors to, in the period until the next annual general meeting, resolve on a new issue of shares with preferential rights for the company's shareholders. The total number of shares that may be issued based on the authorisation must be within the limits of the share capital according to the articles of association and may not exceed such number of

poLight ASA - Invitation to presentation of Q1 2023 results

poLight ASA (OSE: PLT) will release its first quarter 2023 results on Thursday 11 May 2023 at 7.00 am CEST. The quarterly report and presentation will be made available on the company's website www.polight.com and www.newsweb.no. CEO Øyvind Isaksen and CFO Alf Henning Bekkevik will present the company's results at 09:00 am CEST at Continental, Stortingsgaten 24/26, in Oslo, Norway which is open to the public. The presentation and supporting material will be in English. The presentation can also be followed through live webcast. Please join the Q1 2023 results webcast by clicking https:

Asarina Pharma’s positive Phase IIa Tourette Syndrome results to be presented at TicCon, the Virtual National Conference of the Tourette Association of America

(Stockholm, May 5, 2023) On May 19, 2023 Asarina Pharma’s positive results from its Phase IIa Study in Tourette Syndrome will be presented at TicCon, the Virtual National Conference of the Tourette Association of America, by Assoc. Prof. Marco Bortolato (Dept Pharmacology & Toxicology, University of Utah). The results were an important target validation of Assoc Prof. Bortolato’s thesis that the powerful neurosteroid Allopregnanolone (ALLO) is a key target in the pathogenesis of Tourette, and that Asarina’s endogenous compound Sepranolone modulates ALLO´s effects.The Phase IIa results

Safello enables instant payments

Stockholm, 5 May 2023 | Safello, the leading crypto exchange in the Nordics, announces that instant payments are now available as a payment method for transactions.  Safello’s customers can now safely buy digital assets using an instant payment method. The option to use instant payments is provided by a third party payment service provider. Customers choosing instant payment enters into an agreement with the payment service provider that executes payments via open banking API’s. The payment service provider is a registered Swedish entity, licensed as a payment institution under the SFSA

Implantica presents the first quarter 2023 on May 12 at 15:00 CET

Implantica AG (publ) invites investors to a presentation of the first quarter 2023 at 15:00 CET on May 12. The interim report for the first quarter will be published at 8:00 a.m. CET on the same day.The presentation will be in English via an audiocast with teleconference: Conference call dial-in: · Sweden: +46 8 505 163 86 · United Kingdom: +44 20 319 84884 · United States: +1-412-317-6300 Pin code: 9354290# Webcast: · https://ir.financialhearings.com/implantica-q1-2023  Speakers: · CEO Peter Forsell ·

There are no items matching the current filter
There are no more items matching the current filter
Back to top